✦ LIBER ✦

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

✍ Scribed by Maria Simonsson,Viktoria Söderlind,Maria Henningson…

Book ID: 126353522
Publisher: Springer Netherlands
Year: 2013
Tongue: English
Weight: 430 KB
Volume: 24
Category: Article
ISSN: 0957-5243
DOI: 10.1007/s10552-013-0169-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in hormone receptors and prolife

Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response

✍ A. Makris; T.J. Powles; D.C. Allred; S. Ashley; M.G. Ormerod; J.C. Titley; M. Do 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 53 KB

PO125 INFLUENCE OF HER2 STATUS ON METAST

PO125 INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY

✍ Spasojevic, Ivana Bozovic; Susnjar, Snezana; Kovacevic, Marijana Milovic; Konsta 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Prognostic factors of early distant recu

Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy : Results of a retrospective analysis

✍ Marc Debled; Gaëtan MacGrogan; Véronique Brouste; Simone Mathoulin-Pelissier; Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## BACKGROUND Current adjuvant hormone therapy in postmenopausal women with breast cancer is debatable between upfront aromatase inhibitors (AIs) and sequential treatment with tamoxifen. A major concern is the higher rate of early recurrences observed with sequential treatment. The aut

Cyclin D-1, Interleukin-6, HER-2/neu, Tr

Cyclin D-1, Interleukin-6, HER-2/neu, Transforming Growth Factor Receptor-II and Prediction of Relapse in Women with Early Stage, Hormone Receptor-Positive Breast Cancer Treated with Tamoxifen

✍ Hyman B. Muss; Janice Yanushka Bunn; Abigail Crocker; Karen Plaut; James Koh; Ni 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Hormone Receptors and HER-2 Status as Su

Hormone Receptors and HER-2 Status as Surrogates for Histological Subtypes Prognosticate for Disease Control in Node Negative Asian Breast Cancer Patients Treated with Breast Conservation Therapy

✍ F. Wong; E. Chua 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Serum epidermal growth factor is associa

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

✍ Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 366 KB